Bristol Myers Squibb recalls

Bristol Myers Squibb appears in 5 official U.S. recall notices indexed by RecallRadar, most recently on 2025-10-29.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squib…
  FDA Drug · Class II · 2025-10-29 · Bristol Myers Squibb
• EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc
  FDA Drug · Class I · 2017-07-19 · Bristol Myers Squibb
• Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 6 Tablets per Carton, 2.5 mg/1000 mg…
  FDA Drug · Class II · 2012-10-31 · Bristol Myers Squibb
• Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 7 Tablets per Carton, 5 mg/500 mg, R…
  FDA Drug · Class II · 2012-10-31 · Bristol Myers Squibb
• BiCNU (Carmustine for injection) 100 mg and Diluent Rx Only BiCNU manufactured by: Ben Venue Laboratories, Inc
  FDA Drug · Class I · 2012-10-31 · Bristol Myers Squibb